NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 596 / 982

  1. Belongingness and Burdensomeness in Adolescents: Slovene Translation and Validation of the Interpersonal Needs Questionnaire2016 · Crossref
  2. Beneficial effects of Bacopa monnieri extract on opioid induced toxicity2016 · OpenAlex
  3. Benefits and barriers to expanding the availability of take-home naloxone in Australia: A qualitative interview study with service providers2016 · OpenAlex
  4. Benefits of Acetylcholinesterase inhibitor glutamine in Treatment of Alzheimer’s disease and instrumental methods for its analysis in medicinal plants2016 · Crossref
  5. Benefits of peer support groups in the treatment of addiction2016 · OpenAlex
  6. Benzodiazepine Dependence among Young Adult Participants in the Club Scene Who Use Drugs2016 · OpenAlex
  7. Benzodiazepine prescription for patients in treatment for drug use disorders: a nationwide cohort study in Denmark, 2000–20102016 · OpenAlex
  8. Benzodiazepine use, misuse, and abuse: A review2016 · OpenAlex
  9. Benzodiazepines: sedation and agitation2016 · Crossref
  10. Bereavement Following Substance Misuse2016 · OpenAlex
  11. Best practices in LGBT care: A guide for primary care physicians2016 · OpenAlex
  12. Betel Quid and Oral Potentially Malignant Disorders in a Periurban Township in Myanmar2016 · OpenAlex
  13. Between a Rock and a Hard Place: Can Physicians Prescribe Opioids to Treat Pain Adequately While Avoiding Legal Sanction?2016 · OpenAlex
  14. Between ecstasy and reason: a symbolic interpretation of UDV trance2016 · OpenAlex
  15. Between the Bazaar and the Bench: Making of the Drugs Trade in Colonial India, ca. 1900–19302016 · Crossref
  16. Beyond ghosts, gangs and good sorts: Commercial cannabis cultivation and illicit enterprise in England’s disadvantaged inner cities2016 · Crossref
  17. Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?2016 · OpenAlex
  18. Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex2016 · OpenAlex
  19. Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria2016 · OpenAlex
  20. Biased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased μ opioid receptor agonists2016 · OpenAlex
  21. Bidirectional Associations Between Cannabis Use and Depressive Symptoms From Adolescence Through Early Adulthood Among At-Risk Young Men2016 · OpenAlex
  22. Bidirectional Relationship between the Body Mass Index and Substance Use in Young Men2016 · Crossref
  23. Bilateral Transcranial Magnetic Stimulation of the Prefrontal Cortex Reduces Cocaine Intake: A Pilot Study2016 · OpenAlex
  24. Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine Transporters.2016 · PubMed
  25. Binge drinking and internalised sexual stigma among Italian lesbian, gay and bisexual young adults2016 · Crossref
  26. Bioactive Peptides from Angelica sinensis Protein Hydrolyzate Delay Senescence in Caenorhabditis elegans through Antioxidant Activities2016 · OpenAlex
  27. Biocatalytic retrosynthesis: Redesigning synthetic routes to high-value chemicals2016 · OpenAlex
  28. Biological functions of selenium and its potential influence on Parkinson's disease2016 · OpenAlex
  29. Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition2016 · OpenAlex
  30. Biology, Genetics, and Environment: Underlying Factors Influencing Alcohol Metabolism2016 · OpenAlex
  31. Biomarker-Based Approaches for Assessing Alcohol Use Disorders2016 · Crossref
  32. Biosynthetic Pathways of Purine and Pyridine Alkaloids in Coffee Plants2016 · Crossref
  33. Biphasic Effects of α-Asarone on Immobility in the Tail Suspension Test: Evidence for the Involvement of the Noradrenergic and Serotonergic Systems in Its Antidepressant-Like Activity2016 · OpenAlex
  34. Bipolar disorder and substance use disorders. Madrid study on the prevalence of dual disorders/pathology2016 · Crossref
  35. Bipolar disorder increases risk for substance use disorder in teens2016 · Crossref
  36. Blunt Craniofacial Trauma as a Manifestation of Excited Delirium Caused by New Psychoactive Substances2016 · Crossref
  37. Bongs and baby boomers: Trends in cannabis use among older Australians2016 · Crossref
  38. Bowel Disorders.2016 · PubMed
  39. Brain Activity toward Gaming-Related Cues in Internet Gaming Disorder during an Addiction Stroop Task2016 · OpenAlex
  40. Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents2016 · Crossref
  41. Brain Cortical Thickness Differences in Adolescent Females with Substance Use Disorders2016 · OpenAlex
  42. Brain Reward Circuits in Morphine Addiction2016 · OpenAlex
  43. Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets.2016 · PubMed
  44. Brazilian Ayahuasca religions in perspective2016 · OpenAlex
  45. Breaking the Taboo: Illicit Drug Use among Adolescents with Type 1 Diabetes Mellitus2016 · Crossref
  46. Broad Screening and Identification of Novel Psychoactive Substances in Plasma by High-Performance Liquid Chromatography–High-Resolution Mass Spectrometry and Post-run Library Matching2016 · OpenAlex
  47. BSAFER: A Web-Based Intervention for Drug use and Intimate Partner Violence Demonstrates Feasibility and Acceptability among Women in the Emergency Department2016 · Crossref
  48. Building Evidence-Based Tobacco Treatment in the Eastern Mediterranean Region: Lessons Learned by the Syrian Center for Tobacco Studies2016 · Crossref
  49. Building recovery capital through peer harm reduction work2016 · Crossref
  50. Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study2016 · Crossref
  51. Buprenorphine implant non‐inferior to sublingual form in outpatient trial2016 · Crossref
  52. Buprenorphine/naloxone addiction in a pharmacist as a result of migraine self-treatment2016 · Crossref
  53. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant2016 · Crossref
  54. Buveurs de Kava by Patricia Siméoni and Vincent Lebot (review)2016 · OpenAlex
  55. BZP-‘Party pills’, populism and prohibition: Exploring global debates in a New Zealand context2016 · Crossref
  56. Caffeine Concentrations in Coffee, Tea, Chocolate, and Energy Drink Flavored E-liquids2016 · Crossref
  57. Can boredom help? Increased prosocial intentions in response to boredom2016 · OpenAlex
  58. Can ecstasy treat the agony of PTSD?2016 · Crossref
  59. Can human rights standards help protect children and youth from the detrimental impact of alcohol beverage marketing and promotional activities?2016 · Crossref
  60. Can student health professionals accurately estimate alcohol content in commonly occurring drinks?2016 · Crossref
  61. Can You Pass the Acid Test? Critical Review and Novel Therapeutic Perspectives of Δ 9 -Tetrahydrocannabinolic Acid A2016 · OpenAlex
  62. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.2016 · PubMed
  63. Candidate gene networks and blood biomarkers of methamphetamine-associated psychosis: an integrative RNA-sequencing report2016 · OpenAlex
  64. Candy of Cannabis sativa L.- A traditional intoxicant in Udaipur, Rajasthan2016 · Crossref
  65. Canine Detection of the Volatilome: A Review of Implications for Pathogen and Disease Detection2016 · OpenAlex
  66. Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence2016 · OpenAlex
  67. Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway2016 · OpenAlex
  68. Cannabidiol disrupts the reconsolidation of contextual drug‐associated memories in Wistar rats2016 · Crossref
  69. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.2016 · PubMed
  70. Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose2016 · OpenAlex
  71. Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation2016 · OpenAlex
  72. Cannabidiol Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells2016 · OpenAlex
  73. Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells2016 · OpenAlex
  74. Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats2016 · OpenAlex
  75. Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells2016 · OpenAlex
  76. Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders2016 · OpenAlex
  77. Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats2016 · OpenAlex
  78. Cannabinoid derivatives and the pharmacological management of pain2016 · OpenAlex
  79. Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen‐induced pulmonary inflammation in mice2016 · OpenAlex
  80. Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine2016 · OpenAlex
  81. Cannabinoid receptor type-1: breaking the dogmas2016 · OpenAlex
  82. Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease2016 · OpenAlex
  83. Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention2016 · Crossref
  84. Cannabinoids for fibromyalgia2016 · OpenAlex
  85. Cannabinoids for Symptom Management and Cancer Therapy: The Evidence2016 · OpenAlex
  86. Cannabinoids for treatment of glaucoma2016 · OpenAlex
  87. Cannabinoids in Medical Practice2016 · OpenAlex
  88. Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood2016 · OpenAlex
  89. Cannabinoids: Medical implications2016 · OpenAlex
  90. Cannabis ( Cannabis sativa or C. indica ) agriculture and the environment: a systematic, spatially-explicit survey and potential impacts2016 · OpenAlex
  91. Cannabis : état des lieux des législations européennes sur l’usage2016 · Crossref
  92. Cannabis and development of dual diagnoses: A literature review2016 · OpenAlex
  93. Cannabis and tolerance: acute drug impairment as a function of cannabis use history2016 · Crossref
  94. Cannabis Control and Crime: Medicinal Use, Depenalization and the War on Drugs2016 · Crossref
  95. Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder2016 · Crossref
  96. Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: a longitudinal study2016 · OpenAlex
  97. Cannabis microbiome sequencing reveals several mycotoxic fungi native to dispensary grade Cannabis flowers2016 · Crossref
  98. Cannabis policy and the uptake of treatment for cannabis‐related problems2016 · Crossref
  99. Cannabis Regulation in Uruguay: An Innovative Law Facing Major Challenges2016 · Crossref
  100. Cannabis sativa: The Plant of the Thousand and One Molecules.2016 · PubMed